Isabel Urrutia‐Landa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabel Urrutia‐Landa has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Aida Quero‐Martínez
Silicosis National Institute, Oviedo Asturias Spain
1 shared publication- Ana Fernández-Tena
University of Oviedo, Hospital Universitario Central de Asturias (HUCA), Avda de Roma s/n, 33011 Oviedo, Spain
1 shared publication Antonio Santa Cruz‐Siminiani
Santa Lucia Hospital, Cartagena Murcia Spain
1 shared publicationBelén Marín‐Martínez
Navarra University Hospital Pamplona Spain
1 shared publicationCarmen Diego‐Roza
Complexo Hospitalario Universitario de Ferrol La Coruña Spain
1 shared publication- Cristina Martínez González
Asturias Central University Hospital Oviedo Spain
1 shared publication
Latest Publications
- 17 May 2026
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 69 (8) , 614-621
Asbestos‐Related Respiratory Diseases in Spain: Insights From the Spanish Registry
Introduction: Although many Spanish workers have been exposed to asbestos, asbestos‐related diseases (ARD) have not been widely reported in this country. The aim of the present study was to analyze the data recorded in the Spanish Registry of asbestos‐derived diseases. Methods: A retrospective observational study was conducted based on data reported between September 19, 2018, and May 15, 2023, covering 11 Spanish autonomous communities. Variables included demographic data, type of exposure, symptoms, pulmonary function tests, radiological studies, and initial and follow‐up diagnoses. Results: One thousand seven hundred and twenty‐one cases were reported, with a mean age of 75.2 years. The majority were men (96.7%) and were smokers or former smokers (78.8%). Occupational exposure accounted for 98.3% of cases, mainly in the naval sector (70%). Pleural plaques were the most prevalent diagnosis (82.1%), followed by asbestosis (14.9%) and lung cancer (11%). During follow‐up, 181 new diagnoses were made, including lung cancer (23.76%) and mesothelioma (11.6%). The overall mortality rate was 13.4%, with lung cancer being the leading cause of death. Conclusions: This study provides a first overview of ARD in Spain. The most notable findings are the importance of shipyards as a source of exposure, the predominance of pleural plaques and the number of new diagnoses made during the follow‐up, and the need for continuous surveillance and early diagnosis to mitigate asbestos‐related adverse effects.
- 17 May 2026
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 69 (8) , 614-621
Asbestos‐Related Respiratory Diseases in Spain: Insights From the Spanish Registry
Introduction: Although many Spanish workers have been exposed to asbestos, asbestos‐related diseases (ARD) have not been widely reported in this country. The aim of the present study was to analyze the data recorded in the Spanish Registry of asbestos‐derived diseases. Methods: A retrospective observational study was conducted based on data reported between September 19, 2018, and May 15, 2023, covering 11 Spanish autonomous communities. Variables included demographic data, type of exposure, symptoms, pulmonary function tests, radiological studies, and initial and follow‐up diagnoses. Results: One thousand seven hundred and twenty‐one cases were reported, with a mean age of 75.2 years. The majority were men (96.7%) and were smokers or former smokers (78.8%). Occupational exposure accounted for 98.3% of cases, mainly in the naval sector (70%). Pleural plaques were the most prevalent diagnosis (82.1%), followed by asbestosis (14.9%) and lung cancer (11%). During follow‐up, 181 new diagnoses were made, including lung cancer (23.76%) and mesothelioma (11.6%). The overall mortality rate was 13.4%, with lung cancer being the leading cause of death. Conclusions: This study provides a first overview of ARD in Spain. The most notable findings are the importance of shipyards as a source of exposure, the predominance of pleural plaques and the number of new diagnoses made during the follow‐up, and the need for continuous surveillance and early diagnosis to mitigate asbestos‐related adverse effects.